Endast för hälso-och sjukvårdspersonal

Produktresumé för våra godkända läkemedel på FASS:  Breyanzi® (lisokabtagen-maraleucel)

How to tackle unmet needs in DLBCL?

Duration: 2 minutes

In this interview Professor Sirpa Leppä, Helsinki University Hospital, outlines practical focus areas for the DLBCL working group within the Nordic Lymphoma Group. Listen in to what Prof Leppä shares on high risc populations.

Related videos

Biomarkers in LBCL
Optimizing CAR-T Bridging Therapy in LBCL

News

Learn about current topics in hematology, such as new research data, news from events, congresses and more.

Education

Find past and upcoming educational events and access learning tools such as webinars, training videos and expert interviews.

HE-SE-2400027 FEB25 video/ 2009-SE-2500035 01/2026